SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as community members discuss Elon Musk's recent purchase of $1 billion in TSLA shares, which many see as a strong signal of confidence. The move has sparked discussions about a potential short squeeze and the stock's future trajectory, with some anticipating a continued rally while others remain skeptical of the company's fundamentals.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

Shares of ATYR are trending down following the release of Phase 3 study results, with the community discussing whether the stock is now undervalued given its cash position and potential for a rebound. Some traders are weighing the possibility of a dead cat bounce or long-term recovery, while others express concerns about the company's future prospects. The stock's significant drop has sparked debates about risk management and the influence of social media on investment decisions.

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is trending due to speculation around its SOL Treasury company launch and a PIPE offering, with excitement around potential crypto-related gains; however, the community is also discussing concerns regarding dilution, insider trading, and a potential pump and dump scheme, in addition to the inability to trade the stock on some platforms.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Asset Entities Inc.

Asset Entities Inc. ($ASST) is trending due to high volatility following its merger, with discussions focused on trading halts and the potential for a short squeeze. The community is debating the impact of a new share repurchase program and potential Bitcoin purchases, while also noting the CUSIP change affecting trading on some platforms. Overall, traders are closely watching the stock's price action and the potential for significant swings.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors discuss a potential TikTok deal and JD Vance's show on the platform, while also focusing on the high short interest. Community talking points include speculation about a short squeeze, the upcoming Rumble wallet, and the impact of Tether's involvement. Broader discussions revolve around the company's cloud business and potential acquisition of Northern Data.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as discussions revolve around potential partnerships and the broader eVTOL sector possibly receiving analyst upgrades. Community members are actively debating short interest, technical levels, and potential catalysts, including the company's participation in a White House eVTOL pilot program. Some investors express concerns about lack of news and relative performance compared to sector peers like Joby Aviation.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to a mix of bullish news, including a new $6.3B cloud capacity deal with Nvidia, and bearish sentiment from Kerrisdale Capital announcing a short position with a 90% downside target. The community is debating the impact of the Nvidia deal, potential UK data center investments, and whether the recent price action is setting up for a short squeeze or a further pullback. Discussions also revolve around insider selling and its effect on investor confidence.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to analyst upgrades and positive sentiment surrounding its potential in the quantum computing sector, further fueled by news of regulatory clearance for its acquisition of Oxford Ionics. Community members are actively discussing the company's future growth prospects, comparing it to other high-growth tech stocks, and speculating on potential government contracts. However, some caution against the high valuation relative to current revenue and profitability.

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

NanoVibronix Inc

NAOV is trending due to a recent patent announcement regarding its ENvue Medical division's technology, sparking significant community interest. Discussions revolve around the stock's low float and potential for a short squeeze, although some traders express caution due to the company's history of reverse stock splits. The stock is seeing increased volume as traders weigh the impact of the patent and speculate on future price movement.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital ($APLD) is trending as investors celebrate news that a tenant, CoreWeave, signed a large order form with NVIDIA, signaling strong demand for data center capacity and AI infrastructure. The community is optimistic about APLD's prospects in the AI sector and anticipates further announcements regarding new partnerships and data center developments. Bullish sentiment is fueled by the potential for a short squeeze and the company's strategic positioning in the growing AI market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Robinhood Markets Inc. (HOOD) stock gained attention in Thursday’s premarket session, drawing significant investor interest after the launch of the new social media platform and other tools at its HOOD summit 2025 in Las Vegas.&nbsp;The company introduced a range of new tools and features, including short selling, futures trading, and artificial intelligence integrations, all designed to deepen user engagement. Following the summit, Wall Street analysts took a positive stance on the fintech company and its fresh products.&nbsp;Barclays analyst Benjamin Budish noted that Robinhood is accelerating the rollout of features, describing the updates as modern and user-friendly. Meanwhile, Piper Sandler analyst Patrick Moley highlighted the importance of short selling and social trading capabilities.Robinhood Markets' stock inched 0.4% higher in Thursday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;<figure class="image"><img style="aspect-ratio:939/101;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_070849_png_a7c4267e61.webp" alt="HOOD’s Sentiment Meter and Message Volume as of 07:00 a.m. ET on Sep. 11, 2025 | Source: Stocktwits" width="939" height="101"><figcaption>HOOD’s Sentiment Meter and Message Volume as of 07:00 a.m. ET on Sep. 11, 2025 | Source: Stocktwits</figcaption></figure>The stock saw a 95% increase in user message count over the past week.&nbsp;&nbsp;One of the most talked-about additions is “Robinhood Social,” a new platform feature set to launch in early 2026. The feature aims to turn trading into a more interactive experience, allowing users to share strategies and view peer activity. Piper Sandler analyst Patrick Moley believes this concept could unlock huge potential, especially among younger, community-driven investors.The company is also integrating new artificial intelligence tools, branded as “Cortex,” aimed at providing traders with real-time data insights and more personalized recommendations.KeyBanc’s Alex Markgraff raised the price target on the stock to $135 from $120, maintaining an ‘Overweight’ rating. He sees the platform’s expansion as a catalyst for increased trading volume and deeper wallet share among users.Robinhood Markets' stock has gained over 215% in 2025 and over 469% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/goldman-sachs-ceo-sees-25-bps-fed-rate-cut-as-done-deal/chwN5NiRdH4">Will Fed Cut Rates Next Week? What Goldman Sachs CEO David Solomon Predicts For September Meeting And Rest Of 2025</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Robinhood Markets Inc. 

Robinhood Draws Wall Street Praise Over Launch Of New Social Media Platform At HOOD Summit – More Details Inside

Barclays analyst Benjamin Budish noted that Robinhood is accelerating the rollout of features, describing the updates as modern and user-friendly. 

Equity

Barclays analyst Benjamin Budish noted that Robinhood is accelerating the rollout of features, describing the updates as modern and user-friendly. 


BioXcel Therapeutics, Inc. (BTAI) announced on Wednesday that its BXCL501 demonstrated continued effects and consistent benefit with repeat dosing in the treatment of agitation associated with bipolar disorders or schizophrenia in a late-stage trial.BXCL501 is an investigational, orally dissolving film formulation of Dexmedetomidine, marketed by the company as Igalmi. While the primary objective of the trial was to ascertain the safety of the formulation in an at-home setting, the continued effects and consistent benefits observed with repeat dosing in the trial further support the potential of BXCL501 for use in the outpatient setting, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-reports-positive-topline-exploratory">said</a>.Shares of the company rose 3% in the pre-market session. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/BTAI">BTAI stock</a> rose from ‘extremely bearish’ to ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘extremely low’ levels.BioXcel <a href="https://stocktwits.com/news-articles/markets/equity/bioxcel-sublingual-film-well-tolerated-in-bipolar-schizophrenia-trial-in-at-home-settings/chsU5sURdl5">reported</a> late last month that the drug was well-tolerated in the study. The company said that the data from the study will form the basis of a submission to the U.S. Food and Drug Administration (FDA) slated for the first quarter of 2026 and aimed at expanding the label for Dexmedetomidine in the at-home setting.“These positive results, along with the safety and tolerability data previously announced, reinforce BXCL501’s potential in the at-home setting where there is substantial unmet need with no FDA-approved options currently available,” said BioXcel CEO Vimal Mehta.The company said that a total of 246 patients were part of the trial, and 2,437 agitation episodes in 208 patients were treated. All patients were able to successfully self-administer the film, and an average of 11.7 agitation episodes were recorded per treated patient.Igalmi is already approved for the acute treatment of agitation associated with bipolar I or II disorder or schizophrenia in medically supervised settings.BTAI stock is down by 40% this year and by 59% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-futures-edge-lower-ahead-of-inflation-data/chwkJpfRduc">Dow Futures Edge Lower As Investors Turn Cautious Ahead Of Inflation Data: ORCL, KLAR, HOOD, GME Among Stocks To Watch</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study

The company stated that the continued effects and consistent benefits observed with repeat dosing in the trial support the potential of BXCL501 for use in the outpatient setting. 

Professional Diversity Network, Inc. (IPDN) stated on Friday that it has signed a non-binding memorandum of understanding (MOU) with OOKC Group to develop the world’s first compliance-driven Web3.0 digital investment banking platform.OOKC Group is a fintech company focused on building infrastructure for digital capital markets. Under the new initiative with IPDN, the two parties will focus on tokenizing real-world assets, Web3.0 project financing, decentralized capital structures, and cross-border regulatory innovation, it <a target="_blank" rel="noopener noreferrer nofollow" href="https://investor.ipdn.com/press-releases/detail/211/professional-diversity-network-inc-announces-a">said</a>.Professional Diversity Network CEO Xun Wu said that the collaboration represents a “significant strategic step” for the company as it begins to explore opportunities in the virtual asset and digital finance markets. The firm is a global developer and operator of online networks that provides access to networking, training, and employment opportunities for diverse professionals.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/IPDN">IPDN stock</a> jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘extremely low’ to ‘extremely high’ levels. Shares of the company traded 407% higher at the time of writing.<figure class="image"><img style="aspect-ratio:620/66;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_29_at_12_29_38_PM_png_a15e95b51c.webp" alt="IPDN's Sentiment Meter and Message Volume as of 12:37 p.m. ET on Aug. 29, 2025 | Source: Stocktwits" width="620" height="66"><figcaption>IPDN's Sentiment Meter and Message Volume as of 12:37 p.m. ET on Aug. 29, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user stated that they expect the stock to rally further, potentially reaching $10.<stembedurl>https://stocktwits.com/AllorNothingTrading/message/627033032</stembedurl>The company also announced that its business unit TalentAlly, the job board dedicated to connecting talent with employers, will launch an updated website. TalentAlly has seen a 44.3% increase in monthly site visitors and a 79.8% increase in monthly page views since January 2025, according to the company.The enhancements on the website are expected to boost engagement across the platform, leading to more return visits from job seekers, more job views and applications for employers, and stronger career matches, the company stated.IPDN stock is up by 96% this year and 118% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/bumble-developing-ai-powered-matchmaking-app-report/chtTlsuRdNm">Bumble Developing AI-Powered Matchmaking App: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Professional Diversity Network Stock Exploded Over 400% Today – Here’s An Update

The company stated that it has signed a non-binding memorandum of understanding with OOKC Group to develop the world’s first compliance-driven Web3.0 digital investment banking platform.

BioXcel Therapeutics, Inc. (BTAI) on Wednesday said that its late-stage trial evaluating the safety of the company’s BXCL501 as a treatment for agitation associated with bipolar disorders or schizophrenia in the at-home setting met its primary goal of being well-tolerated.BXCL501 is an investigational, orally dissolving film formulation of Dexmedetomidine. The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-announces-serenity-home-pivotal-phase-3">said</a> that the data from the study will form the basis of a submission to the U.S. Food and Drug Administration slated for the first quarter of 2026 and aimed at expanding the label for its dexmedetomidine sublingual film called Igalmi in the at-home setting.Igalmi is already approved for the acute treatment of agitation associated with bipolar I or II disorder or schizophrenia in medically supervised settings.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/BTAI">BTAI stock</a> jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:624/65;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_27_at_9_42_20_AM_png_54402b6e8c.webp" alt="BTAI's Sentiment Meter and Message Volume as of 9:42 a.m. ET on Aug. 27, 2025 | Source: Stocktwits" width="624" height="65"><figcaption>BTAI's Sentiment Meter and Message Volume as of 9:42 a.m. ET on Aug. 27, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user recommended buying the shares of the company.<stembedurl>https://stocktwits.com/Michael17711771/message/626688937</stembedurl>Another user opined that the study results are very promising long term.<stembedurl>https://stocktwits.com/They_call_me_tater_salad/message/626688733</stembedurl>BioXcel said that no discontinuations due to tolerability were observed in the arm of the study that received BXCL501.“By meeting its primary endpoint, the SERENITY At-Home Pivotal Phase 3 trial reinforces BXCL501’s potential to be safely used at home like it is already used in the previously FDA approved institutional setting. The unmet medical need in the at-home setting is significant with no FDA-approved treatments,” CEO Vimal Mehta said, while adding that the company believes the total addressable market is “significantly larger” than previously reported.The company said that a total of 246 patients were part of the trial, and 2,437 agitation episodes in 208 patients were treated. All patients were able to successfully self-administer the film, and an average of 11.7 agitation episodes were recorded per treated patient.The company said that available data demonstrate that treatment with BXCL501 regularly reduced symptoms of agitation throughout the trial. A greater percentage of patients experiencing mild, moderate, or severe agitation had full resolution of symptoms in the BXCL501 arm compared with placebo. Complete analyses of the full data set are ongoing and will be shared in time, the company said.BTAI stock is down by 24% this year and by 57% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/mannkind-united-therapeutics-expand-agreement-to-develop-second-investigational-molecule-together/chsURMTRdkC">MannKind, United Therapeutics Expand Agreement To Develop A Second Investigational Molecule Together</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later

The company said that no discontinuations due to tolerability were observed in the arm of the study that received BXCL501.

A group of investors led by New York-based MCR Hotels is nearing a deal to acquire Soho House &amp; Co (SHCO), valuing the private members club chain for $1.8 billion without debt, the Wall Street Journal reported late Sunday, citing people familiar with the matter.According to the report, investors plan to pay $9 for the company's outstanding public stock, which is over 18% higher than the stock's $7.64 closing price on Friday. Soho House's controlling shareholder, Ron Burkle, and certain other shareholders will roll over their stakes.Apollo Global Management is expected to provide more than $700 million in equity and debt financing, the&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/business/soho-house-members-club-nearing-a-deal-to-go-private-fcae011c">report</a> added.The potential deal would effectively end an activist campaign by Dan Loeb and his hedge fund Third Point, which had disclosed a 10% stake in Soho House in January and had been pushing the company to consider outside bidders following a $9-a-share takeover bid.Soho House was founded in London in 1995 and opened a club in New York in 2003. The clubs, which give members access to private dining, bars, and live events, have gained prominence over the years,&nbsp;getting a significant boost after a Soho House club was featured in an episode of "Sex and the City." Celebrities like Lady Gaga, Prince Harry, and Meghan Markle have reportedly been spotted at Soho clubs.The business has struggled at times to balance rapid growth with exclusivity, as members have complained that the service has slowed with increased membership and that pool spots are scarce.More recently, Soho House's financial results have improved. The company earlier this month reported its third straight quarter of net profit. The second-quarter results showed that membership revenue grew at 15.9% year-over-year.<a href="https://stocktwits.com/symbol/SHCO">Soho House</a> went public in 2021. Its shares are up 2.6% year-to-date. On Stocktwits, the retail sentiment was 'bullish' for the stock as of the last reading.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Soho House in Shoreditch, the UK. (Photo by Doug Peters/Penske Media via Getty Images)

Soho House Nears $9-Share Go-Private Deal: Report

The bidders are led by New York-based MCR Hotels, and the deal might be announced as early as Monday.

Workhorse Group Inc. (WKHS) and Motiv Electric Trucks on Friday announced that they have entered into a definitive merger agreement to combine in a transaction.The combination will bring together two companies in the medium-duty electric vehicle space to create a leading North American medium-duty electric truck original equipment manufacturer (OEM) with a full range of Class 4-6 trucks valued at about $105 million, the firms <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.workhorse.com/news-events/press-releases/detail/303/workhorse-group-and-motiv-electric-trucks-executed">said</a>.Scott Griffith, Motiv CEO, is expected to serve as CEO of the combined company, and Rick Dauch, Workhorse CEO, is expected to serve as an advisor to the combined firm. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/WKHS">WKHS</a> jumped from ‘bearish’ to ‘neutral’ over the past 24 hours, while message volume remained at ‘low’ levels.<figure class="image"><img style="aspect-ratio:627/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_15_at_11_44_53_AM_png_f5def64568.webp" alt="WKHS's Sentiment Meter and Message Volume as of 11:45 a.m. ET on Aug. 15, 2025 | Source: Stocktwits" width="627" height="61"><figcaption>WKHS's Sentiment Meter and Message Volume as of 11:45 a.m. ET on Aug. 15, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user sounded optimistic about the merger.<stembedurl>https://stocktwits.com/GurtGobby/message/625356934</stembedurl>However, another user said the market is not buying the $105 million valuation on the combined company.<stembedurl>https://stocktwits.com/DrummerWI/message/625348066</stembedurl>Under the deal, Motiv will be merged with a newly created subsidiary of Workhorse in exchange for newly issued shares of Workhorse common stock. Upon closing of the transaction, on a fully diluted basis, Motiv’s controlling investor initially will own approximately 62.5% of the combined company, Workhorse shareholders will own approximately 26.5% and Workhorse’s existing senior secured lender will have rights to receive common stock that represent approximately 11%.The transaction is expected to close in the fourth quarter of 2025, subject to Workhorse shareholder approval and other customary closing conditions. The companies said they believe the deal will provide significant benefits to customers and shareholders by strengthening the combined company’s financial position and creating opportunities for margin expansion.The firms further believe there is potential to achieve at least $20 million of cost synergies, through research and development, general and administrative, and facility cost-reductions by the end of 2026.&nbsp;WKHS stock is down by 81% this year and by about 88% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/lyft-has-steady-path-forward-according-to-ubs/chsPszdRdf8">Lyft Has A ‘Steady Path Forward’ According To UBS: Retail Thinks Stock Is Undervalued</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Workhorse Group logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Workhorse Group To Merge With Motive Electric Trucks: Retail’s Divided On The Combined Company Valuation

The combination will create a leading North American medium-duty electric truck original equipment manufacturer with a full range of Class 4-6 trucks valued at about $105 million, the companies said.

Verb Technology Company Inc. (VERB) is changing its business focus and plans to rename itself as it aims to hold Toncoin (TON) as a core asset, a digital currency linked to Telegram’s growing blockchain network.The Las Vegas-based firm said it has priced an upsized and oversubscribed private placement expected to generate approximately $558 million in gross proceeds. The funds will primarily be used to accumulate Toncoin as a long-term reserve asset. Following the closing of the private placement, expected on or around August 7, the company will operate under the name TON Strategy Co. (TSC).&nbsp;Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/VERB">Verb Technology stock</a> traded up by over 97% on Monday afternoon.On Stocktwits, retail sentiment shifted to ‘extremely bullish’ (88/100) from ‘bullish’ territory the previous day amid ‘extremely high’ (94/100) message volume levels.&nbsp;<figure class="image"><img style="aspect-ratio:956/106;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_04_115719_png_edb23b487a.webp" alt="VERB’s Sentiment Meter and Message Volume as of 12:10 p.m. ET on Aug. 4, 2025 | Source: Stocktwits" width="956" height="106"><figcaption>VERB’s Sentiment Meter and Message Volume as of 12:10 p.m. ET on Aug. 4, 2025 | Source: Stocktwits</figcaption></figure>Both retail sentiment and message volume hit a year-high. The stock experienced a 1,100% explosion in user message count in 24 hours, as of Monday morning.&nbsp;Stocktwits users said they are adding the stock.&nbsp;<stembedurl>https://stocktwits.com/BullsEye2000/message/623633327</stembedurl><stembedurl>https://stocktwits.com/Lizardbronsen/message/623633379</stembedurl>Executives said that TON will serve as its central reserve asset, enabling the firm to earn yield through staking while growing exposure to the token. TSC’s original operations will remain intact and are also expected to scale.The move comes on the heels of Telegram and the TON Foundation establishing $TON as the backbone of Telegram’s ecosystem. Manuel Stotz, CEO of Kingsway Capital and president of the TON Foundation, will take the reins as Executive Chairman.&nbsp;“Telegram is the preferred messenger for the growing global crypto community and $TON is the currency that powers the Telegram ecosystem,” said&nbsp; StotzVeronika Kapustina, a former advisor to TON and ex-Morgan Stanley banker, will serve as CEO. Verb Technology stock has gained over 185% year-to-date and over 31% in the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/steelcase-stock-surged-64-percent-after-this-acquisition/chrXFxYRdTM">Steelcase Stock Surged 64% On Monday After This $2.2B Acquisition: Here’s The Fineprint</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Toncoin (TON) cryptocurrency logo is seen on a smartphone screen. 

Verb Technology Stock Nearly Doubles On Monday, Retail Chatter Explodes A Whopping 1,100%: Here’s What’s Happening

Following the closing of a private placement, expected on or around August 7, the company will operate under the name TON Strategy Co. (TSC). 

Should Vanguard Extended Market ETF (VXF) Be on Your Investing Radar?

IMUNON, Inc. (IMNN) said on Wednesday its first patient has been dosed with the firm’s lead candidate, IMNN-001, as part of a late-stage trial evaluating the drug in the treatment of women with newly diagnosed advanced ovarian cancer.Shares of the company traded 4% higher in morning trade at the time of writing.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/IMNN">IMUNON</a> jumped from ‘bearish’ to ‘neutral’ over the past 24 hours while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:625/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_30_at_9_43_26_AM_png_dc891d230b.webp" alt="IMNN's Sentiment Meter and Message Volume as of 10 a.m. ET on July 30, 2025 | Source: Stocktwits" width="625" height="61"><figcaption>IMNN's Sentiment Meter and Message Volume as of 10 a.m. ET on July 30, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the company is undervalued.<stembedurl>https://stocktwits.com/ConcernedCitizen23/message/623007565</stembedurl>The late-stage <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.imunon.com/news-releases/news-release-details/imunon-announces-first-patient-dosed-phase-3-ovation-3-study">study</a> is aimed at assessing the safety and efficacy of IMNN-001 plus standard of care neoadjuvant and adjuvant chemotherapy of Paclitaxel and Carboplatin compared to standard of care chemotherapy alone.The primary endpoint of the study is overall survival or lengthening the lifespan of patients.The study will also check secondary endpoints such as surgical response score, chemotherapy response score, clinical response, and time to second-line treatment.“We have great urgency around this program because patients do not have any other options besides the standard of care, which includes neoadjuvant and adjuvant chemotherapy and surgery,” CEO Stacy Lindborg said.According to IMUNON, epithelial ovarian cancer is the sixth deadliest malignancy among women in the U.S. There are approximately 20,000 new cases of ovarian cancer every year, and approximately 70% are diagnosed in advanced Stage III/IV, the company said.Earlier this month, IMUNON completed a reverse stock split of its issued and outstanding common stock at a ratio of 1:15 to meet the minimum bid price requirement for continued listing on the Nasdaq.IMNN stock is down by 43% this year and by about 84% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/humana-announces-upbeat-earnings-raised-guidance/choXGmPR5zr">Humana Stock Gains On Upbeat Earnings And Raised Guidance, Draws Retail Praise</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Imunon Doses First Patient With Experimental Cancer Drug In Late-Stage Trial: Retail Thinks Company Is Undervalued

The trial is evaluating IMNN-001 in the treatment of women with newly diagnosed advanced ovarian cancer. 

American Airlines Group Inc. (AAL) reported better-than-expected second-quarter (Q2) earnings on Thursday, but issued a cautious outlook for the third quarter (Q3), sending the stock into a downward spiral.Following the Q2 earnings,&nbsp;<a href="https://stocktwits.com/symbol/AAL">American Airlines stock</a> traded over 7% lower on Thursday morning.However, on Stocktwits, retail sentiment toward the stock improved to ‘extremely bullish’ (80/100) from ‘bullish’ territory the previous day. Message volume jumped to ‘extremely high’ (76/100) from ‘normal’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:964/112;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_24_103022_png_48fb85aa2f.webp" alt="AAL’s Sentiment Meter and Message Volume as of 10.45 a.m. ET on July 24, 2025 | Source: Stocktwits" width="964" height="112"><figcaption>AAL’s Sentiment Meter and Message Volume as of 10.45 a.m. ET on July 24, 2025 | Source: Stocktwits</figcaption></figure>American Airlines experienced a 150% surge in user message count in the last 24 hours.Some Stocktwits users considered the fall in stock price as an opportunity to buy.<stembedurl>https://stocktwits.com/joketrader/message/622275894</stembedurl><stembedurl>https://stocktwits.com/slick5/message/622260253</stembedurl>Another user expressed skepticism about the firm.<stembedurl>https://stocktwits.com/Jzdtown58/message/622266245</stembedurl>The company’s revenue remained almost flat at $14.392 billion, exceeding the analysts’ consensus estimate of $14.293 billion, as per Fiscal AI data. The earnings per share (EPS) of $0.91 also surpassed the estimate of $0.77.The company strengthened its balance sheet significantly in the first half of 2025, generating $3.4 billion in operating cash flow and $2.5 billion in free cash flow.&nbsp;American Airlines ended the quarter with $12 billion in total liquidity, supported by both cash reserves and available credit lines. However, total debt stands at $38 billion, with net debt at $29 billion at the end of Q2.For Q3, the company is projecting an adjusted loss per share between $0.10 and $0.60, below the estimate of a loss of $0.01.For the full year, the company anticipates adjusted EPS to land between a loss of $0.20 and a gain of $0.80.&nbsp;Management noted that the higher end of the range is feasible if U.S. demand holds steady, but macroeconomic headwinds could push results to the lower bound.According to a Bloomberg&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-24/american-air-ceo-says-ai-setting-fares-is-bait-and-switch-move?srnd=homepage-americas">report</a>, CEO Robert Isom strongly criticized the use of artificial intelligence in airline pricing, arguing that it risks misleading passengers.His remarks align with concerns raised by members of Congress, who are pressing Delta Air Lines Inc. (DAL) for details on its AI-driven pricing strategy.&nbsp;American Airlines stock has lost 33% in 2025 and has gained over 14% in the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/servicenow-stock-surges-after-blowout-quarter/ch8yyLsR5HS">ServiceNow Stock Surges After Blowout Quarter, Bullish Retail Buzz Hits New High</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bernstein has reportedly downgraded American Airlines to ‘Market Perform' from ‘Outperform’

American Airlines Sparks Investor Debate After Q2 Beat, Cautious Outlook: Retail’s On Buying Spree

For Q3, American Airlines is projecting an adjusted loss per share between $0.10 and $0.60, below the estimate of a loss of $0.01.

VXF
Vanguard Extended Market ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest VXF News

VXF Vanguard Extended Market ETF